FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/092051 [Registered on: 30/07/2025] Trial Registered Prospectively
Last Modified On: 15/10/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Behavioral 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Improving Life for Women with Endometriosis: A Psychological Intervention Study to Enhance Quality of Life and Reduce Depression 
Scientific Title of Study   Adapting to Better Life with Endometriosis (ABLE): A study to improve quality of life of women with endometriosis and investigate economic burden of the disease. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
Version 5, Dated 05.05.2025  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Preety Rajbangshi 
Designation  Senior Research Fellow, Womens Health 
Affiliation  The George Institute of Global heaalth, India 
Address  308, Third Floor, Elegance Tower, District Centre, Jasola Vihar, New Delhi, Delhi 110025

New Delhi
DELHI
110025
India 
Phone  9711414899  
Fax    
Email  PRajbangshi@georgeinstitute.org.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Susmita Chatterjee 
Designation  Program Head, Health Economics 
Affiliation  The George Institute of Global heaalth, India 
Address  308, Third Floor, Elegance Tower, District Centre, Jasola Vihar, New Delhi, Delhi 110025

New Delhi
DELHI
110025
India 
Phone  9953770639  
Fax    
Email  schatterjee@georgeinstitute.org.in  
 
Details of Contact Person
Public Query
 
Name  Sarah Shabbir Suwasrawala 
Designation  Research Fellow 
Affiliation  The George Institute of Global heaalth, India 
Address  308, Third Floor, Elegance Tower, District Centre, Jasola Vihar, New Delhi, Delhi 110025

New Delhi
DELHI
110025
India 
Phone  8451090164  
Fax    
Email  ssuwasrawala@georgeinstitute.org.in  
 
Source of Monetary or Material Support  
Indian Council of Medical Research (ICMR) V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi – 110029, India 
 
Primary Sponsor  
Name  The George Institute of Global Health, India 
Address  308, Third Floor, Elegance Tower, Plot No. 8, Jasola District Centre, New Delhi, 110025 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Panchanan Das  Guwahati Medical College and Hospital  First Floor, Department of Obstetrics and Gynaecology Office, Gauhati Medical College and Hospital, Kamrup Metropolitan District, Guwahati – 781032, Assam
Kamrup
ASSAM 
9864063488

panchanan_reeti@yahoo.in 
Dr Ranjitha Shetty  Kasturba Medical College (KMC)  Ground Floor, Women and Child Block, Kasturba Hospital, Madhav Nagar Manipal 576104 Udupi District Karnataka
Udupi
KARNATAKA 
9110401395

ranjitha.shetty@manipal.edu 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 3  
Name of Committee  Approval Status 
Guwahati Medical College & Hospital  Approved 
Kasturba Medical College  Approved 
The George Institute Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N809||Endometriosis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Behavioral Activation Treatment for Depression (BATD)-based psychological group sessions  - 8 group sessions over 3-week intervals, including patient education, coping strategies, and mindfulness exercises. - Homework component includes mindfulness practices via handouts, worksheets, and videos.  
Comparator Agent  Routine Medical and psychological care  Treatment as usual, including medical and psychological care as routinely provided at the respective sites. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  49.00 Year(s)
Gender  Female 
Details  Women will be eligible to participate if they meet all of the following criteria:
1. Aged between 18 and 49 years.
2. Have a confirmed diagnosis of endometriosis, either surgically or via transvaginal ultrasound.
3. Reside within 20 km of the study hospital site.
4. Have a PHQ-9 score of 5 or above, indicating at least mild depressive symptoms.
5. Are willing and able to attend all 8 Behavioral Activation (BA) group sessions.
6. Are willing to engage in homework (30–40 minutes weekly) involving mindfulness activities and worksheets.

$$$$$$
 
 
ExclusionCriteria 
Details  Participants will be excluded if they meet any of the following:
1. Have a severe psychiatric disorder that impairs their ability to provide consent or attend sessions.
2. Are currently pregnant or planning pregnancy during the study period.
3. Have associated malignancies.
4. Are unable to speak and understand any of the following languages: Hindi, English, Kannada, or Assamese.
 
 
Method of Generating Random Sequence   Stratified randomization 
Method of Concealment   Centralized 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in quality of life as measured by WHOQOL-BREF  6 and 12 months 
 
Secondary Outcome  
Outcome  TimePoints 
1. Change in depression score using PHQ-9 at 6 and 12 months
2. Incremental cost analysis from provider perspective
 
6 and 12 months 
 
Target Sample Size   Total Sample Size="480"
Sample Size from India="480" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   01/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The ABLE study (Adapting to Better Life with Endometriosis) aims to improve the quality of life and reduce depressive symptoms in women diagnosed with endometriosis through a structured psychological intervention based on Behavioral Activation Therapy for Depression (BATD). The study also seeks to assess the economic burden of endometriosis on affected women and their families. This individual randomized controlled trial will be conducted at two sites in India, enrolling 480 participants ( 240 each in the intervention and control arms). Women will be randomized to either an intervention group receiving eight group-based BATD sessions or a control group receiving treatment as usual.

Study Hypothesis:
The behavioral activation-based psychological intervention will lead to a significant improvement in quality of life and reduction in depression scores among women with endometriosis compared to standard care.

 
Close